What is First Tracks Biotherapeutics Inc's total equity?

First Tracks Biotherapeutics Inc (TRAX) reported total equity of $257.46M in Q1 2026.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Screener

GPA

General Purpose Acquisition Corp.GPAC

-$7.87M+38.7%

VeradermicsMANE

$390.64M+744%

BKBK

$44.78B+3.9%

Polaryx Therapeutics, Inc.PLYX

$2.49M-41.5%

Schering-PloughSGP

$250.11M+463%

Dollar GeneralDG

$8.84B+14.8%

Reported directly by First Tracks Biotherapeutics Inc in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The source filing: First Tracks Biotherapeutics Inc’s 10-Q, filed May 14, 2026. Open the filing →

What is First Tracks Biotherapeutics Inc's total equity?: First Tracks Biotherapeutics Inc (TRAX) reported total equity of $257.46M in Q1 2026.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Connect your AI assistant and compare it to peers, right in your chat.